These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23393013)

  • 1. Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media.
    Sugita R
    J Infect Chemother; 2013 Jun; 19(3):465-71. PubMed ID: 23393013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure.
    Zielnik-Jurkiewicz B; Bielicka A
    Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2129-33. PubMed ID: 26454530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a novel oral carbapenem, tebipenem pivoxil (TBM-PI), against experimental otitis media caused by penicillin resistant Streptococcus pneumoniae in chinchilla.
    Hotomi M; Suzumoto M; Itahashi K; Nagura J; Fukushima T; Shimada J; Billal DS; Yamauchi K; Fujihara K; Yamanaka N
    Vaccine; 2007 Mar; 25(13):2478-84. PubMed ID: 17055132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics.
    Leibovitz E; Raiz S; Piglansky L; Greenberg D; Yagupsky P; Fliss DM; Leiberman A; Dagan R
    Pediatr Infect Dis J; 1998 Jun; 17(6):463-9. PubMed ID: 9655535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.
    Leibovitz E; Greenberg D; Piglansky L; Raiz S; Porat N; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tissue and aural discharge distribution of tebipenem pivoxil].
    Baba S; Kasahara H; Morita J; Aizawa K; Sunakawa K
    Jpn J Antibiot; 2009 Apr; 62(2):127-35. PubMed ID: 19673354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
    Soriano F; Parra A; Cenjor C; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Ponte C
    J Infect Dis; 2000 Feb; 181(2):646-52. PubMed ID: 10669350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics].
    Sakata H
    Jpn J Antibiot; 2011 Jun; 64(3):171-7. PubMed ID: 21861308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of bacterial pathogens in otitis media with effusion.
    Post JC; Preston RA; Aul JJ; Larkins-Pettigrew M; Rydquist-White J; Anderson KW; Wadowsky RM; Reagan DR; Walker ES; Kingsley LA; Magit AE; Ehrlich GD
    JAMA; 1995 May 24-31; 273(20):1598-604. PubMed ID: 7745773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Streptococcus pneumoniae and Haemophilus influenzae isolated from middle ear fluid before and after the introduction of government subsidies for pneumococcal and H. influenzae type b vaccines in Japan.
    Hoshino T; Takeuchi N; Fukasawa C; Hirose S; Okui H; Sato H; Sato M; Arimoto Y; Nakano A; Ishiwada N
    J Infect Chemother; 2017 Feb; 23(2):85-89. PubMed ID: 27889249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytology of middle ear fluid during acute otitis media.
    Broides A; Leibovitz E; Dagan R; Press J; Raiz S; Kafka M; Leiberman A; Yermiahu T
    Pediatr Infect Dis J; 2002 Jan; 21(1):57-61. PubMed ID: 11791101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antimicrobial treatments in children with acute otitis media in Spain: a pharmacokinetic-pharmacodynamic (PK/PD) approach.
    Beobide I; Canut A; Gascón AR; Isla A; García-Rey C; De La Maza I; Labora A; Pedraz JL
    J Chemother; 2005 Dec; 17(6):628-35. PubMed ID: 16433193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of clinical bacteriological efficacy of oral antibiotics using a mechanism-based pharmacokinetic-pharmacodynamics modeling.
    Matsumoto K; Sugano T; Sato N; Ida T; Shibasaki S
    Jpn J Antibiot; 2014 Feb; 67(1):33-47. PubMed ID: 24809207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of culture and real-time PCR methods in the detection of Streptococcus pneumoniae and Haemophilus influenzae in acute otitis media effusion specimens].
    Eser OK; Alp S; Ergin A; Ipçi K; Alp A; Gür D; Hasçelik G
    Mikrobiyol Bul; 2012 Oct; 46(4):676-81. PubMed ID: 23188581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complicated otitis media and its implications.
    Leibovitz E
    Vaccine; 2008 Dec; 26 Suppl 7():G16-9. PubMed ID: 19094932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections].
    Baba S; Yamanaka N; Suzuki K; Furukawa M; Furuya N; Ubukata K; Totsuka K
    Jpn J Antibiot; 2009 Apr; 62(2):155-77. PubMed ID: 19673357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media.
    Dagan R
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial treatment of otitis media.
    Giebink GS; Canafax DM
    Semin Respir Infect; 1991 Jun; 6(2):85-93. PubMed ID: 1771307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.